Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck CancerAlona Zer, Lori J. Bernstein, Eric X. Chen et al.|JAMA Otolaryngology–Head & Neck Surgery|2017Cited by 56
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C. M. Lau, Adrian G. Sacher, Malcolm Ryan et al.|JTO Clinical and Research Reports|2021Cited by 11
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancerAmit P. Bhavsar, Asna Latif, Erika N. Scott et al.|Journal of Pharmacology and Experimental Therapeutics|2024Cited by 4